Vimian Group delivers effective solutions for animals and veterinary professionals around the world. The Group is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health. Vimian is listed on Nasdaq First North Growth Market.

Vimian has carried out a Directed Issue of plus 51 million ordinary shares at a subscription price of SEK 29 per share. The subscription price was determined through an accelerated bookbuilding procedure. Vimian’s largest shareholder Fidelio subscribed to 32,500,000 shares in the directed share issue.

Vimian’s Board of Directors believes that the proceeds contribute to a good balance of different financing sources and that the Directed Share Issue is positive for the Company’s capital structure and general risk level.